Walleye Trading’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
TI
Walleye Trading's ANIK Position: Q2 2021 in Review
Walleye Trading sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 4,922 shares — an estimated $201K sold.
Walleye Trading first reported a position in ANIK in Q4 2015 and held it in 10 quarters. The position peaked at $359K in Q2 2018. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.
- Walleye Trading reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
- Walleye Trading sold 4,922 Anika Therapeutics shares in Q2 2021, an estimated $201K.
- Walleye Trading first reported a position in Anika Therapeutics in Q4 2015 and held it in 10 quarters.
- Walleye Trading's Anika Therapeutics position peaked at $359K in Q2 2018.
- 139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.
Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.